SG54177A1 - Process for purification of a 69000 dalton antigenic protein from bordetella pertussis - Google Patents

Process for purification of a 69000 dalton antigenic protein from bordetella pertussis

Info

Publication number
SG54177A1
SG54177A1 SG1996003196A SG1996003196A SG54177A1 SG 54177 A1 SG54177 A1 SG 54177A1 SG 1996003196 A SG1996003196 A SG 1996003196A SG 1996003196 A SG1996003196 A SG 1996003196A SG 54177 A1 SG54177 A1 SG 54177A1
Authority
SG
Singapore
Prior art keywords
bordetella pertussis
purification
dalton
antigenic protein
protein
Prior art date
Application number
SG1996003196A
Other languages
English (en)
Inventor
John William Gotto
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of SG54177A1 publication Critical patent/SG54177A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/235—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Bordetella (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/82—Proteins from microorganisms
    • Y10S530/825—Bacteria

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Analytical Chemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG1996003196A 1989-12-11 1990-10-29 Process for purification of a 69000 dalton antigenic protein from bordetella pertussis SG54177A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/448,777 US5276142A (en) 1989-12-11 1989-12-11 Process for purification of a 69000 dalton antigenic protein from Bordetella pertussis

Publications (1)

Publication Number Publication Date
SG54177A1 true SG54177A1 (en) 1998-11-16

Family

ID=23781640

Family Applications (1)

Application Number Title Priority Date Filing Date
SG1996003196A SG54177A1 (en) 1989-12-11 1990-10-29 Process for purification of a 69000 dalton antigenic protein from bordetella pertussis

Country Status (13)

Country Link
US (1) US5276142A (da)
EP (1) EP0437687B1 (da)
JP (1) JP2950970B2 (da)
KR (1) KR0180527B1 (da)
AT (1) ATE137976T1 (da)
AU (1) AU641711B2 (da)
CA (1) CA2031763A1 (da)
DE (1) DE69027013T2 (da)
DK (1) DK0437687T3 (da)
ES (1) ES2087109T3 (da)
FI (1) FI101380B1 (da)
NO (1) NO301717B1 (da)
SG (1) SG54177A1 (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8910570D0 (en) * 1989-05-08 1989-06-21 Wellcome Found Acellular vaccine
US6197548B1 (en) 1990-04-02 2001-03-06 Medeva Pharma Limited Transformed Pichia expressing the pertactin antigen
GB9007657D0 (en) * 1990-04-04 1990-05-30 Connaught Lab Purification of a pertussis outer membrane protein(omp69)
EP0484621A3 (en) * 1990-07-11 1992-08-26 American Cyanamid Company Efficacious vaccines against bordetella pertussis comprising a combination of individually purified pertussis antigens
US6444211B2 (en) 1991-04-03 2002-09-03 Connaught Laboratories, Inc. Purification of a pertussis outer membrane protein
GB9304399D0 (en) * 1993-03-04 1993-04-21 Smithkline Beecham Biolog Novel process
US6051240A (en) * 1994-04-28 2000-04-18 Takeda Chemical Industries, Ltd. Method of separating protective components of Bordetella pertussis
DE19512346C1 (de) * 1995-04-01 1996-06-13 Behringwerke Ag Verfahren zur Reinigung von Filamenthämagglutinin und Pertussis-Toxin
ATE221081T1 (de) 1995-05-04 2002-08-15 Aventis Pasteur Azelluläre pertussis-impfstoffe und verfahren zu deren herstellung
US5877298A (en) * 1995-05-04 1999-03-02 Connaught Lab Acellular pertussis vaccines and methods of preparing thereof
GB9611501D0 (en) * 1996-06-03 1996-08-07 Smithkline Beecham Biolog Vaccine compositions
BRPI9710460B8 (pt) 1996-07-02 2021-05-25 Aventis Pasteur composição imunogênica multi-valente e composição de vacina
EP2430040A1 (en) * 2009-05-11 2012-03-21 Novartis AG Antigen purification process for pertactin antigen
CN102584958A (zh) * 2012-02-08 2012-07-18 北京天坛生物制品股份有限公司 百日咳杆菌69kd外膜蛋白的纯化方法
AP2015008702A0 (en) 2013-03-08 2015-09-30 Crucell Holland Bv Acellular pertussis vaccine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4220717A (en) * 1977-12-22 1980-09-02 American Cyanamid Company Isolation and purification of polyribosyl ribitol phosphate from Haemophilus influenzae type b.
GB8412207D0 (en) * 1984-05-12 1984-06-20 Wellcome Found Antigenic preparations
GB8512972D0 (en) * 1985-05-22 1985-06-26 Univ Glasgow Vaccine production
ATE117899T1 (de) * 1987-09-28 1995-02-15 Beecham Inc Tgev-virus vom schwein als impfstoff für hunde.
US5101014A (en) * 1989-02-10 1992-03-31 United States Of America Process for the purification of a 69,000 da outer membrane protein of Bordetella pertussis

Also Published As

Publication number Publication date
EP0437687B1 (en) 1996-05-15
NO905324D0 (no) 1990-12-10
AU6793390A (en) 1991-06-13
FI101380B (fi) 1998-06-15
CA2031763A1 (en) 1991-06-12
ATE137976T1 (de) 1996-06-15
ES2087109T3 (es) 1996-07-16
DK0437687T3 (da) 1996-06-03
FI906071L (fi) 1991-06-12
JPH03191789A (ja) 1991-08-21
AU641711B2 (en) 1993-09-30
DE69027013T2 (de) 1996-12-19
DE69027013D1 (de) 1996-06-20
FI101380B1 (fi) 1998-06-15
EP0437687A2 (en) 1991-07-24
NO905324L (no) 1991-06-12
JP2950970B2 (ja) 1999-09-20
EP0437687A3 (en) 1991-07-31
NO301717B1 (no) 1997-12-01
KR0180527B1 (ko) 1999-04-01
KR910012234A (ko) 1991-08-07
US5276142A (en) 1994-01-04
FI906071A0 (fi) 1990-12-10

Similar Documents

Publication Publication Date Title
EP0437687A3 (en) Process for purification of a 69000 dalton antigenic protein from bordetella pertussis
DE3561472D1 (en) Process for the extraction of poly-beta-hydroxybutyrates with a solvent from an aqueous suspension of microorganisms
AU533386B2 (en) Isolation of membrane proteins from neisseria meningitidis and vaccines containing same
FI901646A0 (fi) Kiteinen 2-O- -D-glukopyranosyyli-L-askorbiinihappo ja menetelmä sen valmistamiseksi
IT1236039B (it) Gruppo di riscaldamento controllato per l'estrazione del solvente da fanghi per distillazione,in particolare per macchine lavasecco.
HUT56356A (en) Process for producing thiazolidin-4-ones and 1,3-oxathiolan-5-one derivatives
IL111793A0 (en) Process for preparing 2,2-difluoroketene silyl acetals and Alpha,Alpha-difluoro-Beta-silyloxy-1,3 dioxolange-4-propanoic acid esters
AU6859691A (en) Insoluble tannin preparation process, waste treatment process employing insoluble tannin and adsorption process using tannin
GR870917B (en) Novel mehthod of preparing toxoid
ZA908801B (en) Process for purifying antigenic factors from b.pertussis
ZA872711B (en) Affinity chromatography material and its use in the separation and purification of protein antigens of the bacteria of the bordetella genus
EP0090660A3 (en) Neisseria gonorrhoeae vaccine
EP0254239A3 (en) Optically pure 1,3-dioxenones, methods for preparing same and use thereof
EP0685492A3 (de) Verfahren zur Herstellung molekulareinheitlicher hyperpolymerer Hämoglobine.
ZA911475B (en) Process for the separation of yttrium
EP0362638A3 (en) Method of preparing symmetrical and unsymmetrical monoacetals of aromatic 1,2-diketones
FR2592884B1 (fr) Extrait de jacinthe d'eau renfermant des peptides, son procede de preparation et ses utilisations
LIU Comparative study on T-lymphocyte subsets in the patients of excess-heat syndrome and deficiency-heat syndrome
PL285941A1 (en) Method of obtaining novel alkylsirane block copolymers containing 1,3-dioxane group in its molecule
AU6833987A (en) Treating pseudorabis virus infection in swine
YU44386A (en) Process for preparing new n,n'dialkylguanidino dipeptides
IE892369L (en) Bordetella pertussis vaccine
IT1207652B (it) Estrattore oleodinamico per l'estrazione di cuscinetti,pulegge esimili